These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 15340332)

  • 1. [Efficacy of multifactorial preventive interventions in achievement of target levels of low density lipoprotein cholesterol in survivors of myocardial infarction].
    Shalaev SV; Dmitrieva NP; Kremneva LV; Safiullina ZM; Abaturova OV
    Kardiologiia; 2004; 44(8):35-9. PubMed ID: 15340332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid paradox in acute myocardial infarction-the association with 30-day in-hospital mortality.
    Cheng KH; Chu CS; Lin TH; Lee KT; Sheu SH; Lai WT
    Crit Care Med; 2015 Jun; 43(6):1255-64. PubMed ID: 25738856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative importance of different lipid risk factors for the development of myocardial infarction at a very young age (≤ 40 years of age).
    Goliasch G; Oravec S; Blessberger H; Dostal E; Hoke M; Wojta J; Schillinger M; Huber K; Maurer G; Wiesbauer F
    Eur J Clin Invest; 2012 Jun; 42(6):631-6. PubMed ID: 22150092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AMG 145, a monoclonal antibody against PCSK9, facilitates achievement of national cholesterol education program-adult treatment panel III low-density lipoprotein cholesterol goals among high-risk patients: an analysis from the LAPLACE-TIMI 57 trial (LDL-C assessment with PCSK9 monoclonal antibody inhibition combined with statin thErapy-thrombolysis in myocardial infarction 57).
    Desai NR; Giugliano RP; Zhou J; Kohli P; Somaratne R; Hoffman E; Liu T; Scott R; Wasserman SM; Sabatine MS
    J Am Coll Cardiol; 2014 Feb; 63(5):430-3. PubMed ID: 24161333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Target-attainment rates of low-density lipoprotein cholesterol using lipid-lowering drugs one year after acute myocardial infarction in sweden.
    Hambraeus K; Lindhagen L; Tydén P; Lindahl B; Lagerqvist B
    Am J Cardiol; 2014 Jan; 113(1):17-22. PubMed ID: 24169006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-density lipoprotein cholesterol level in patients with acute myocardial infarction having percutaneous coronary intervention (the cholesterol paradox).
    Cho KH; Jeong MH; Ahn Y; Kim YJ; Chae SC; Hong TJ; Seong IW; Chae JK; Kim CJ; Cho MC; Seung KB; Park SJ;
    Am J Cardiol; 2010 Oct; 106(8):1061-8. PubMed ID: 20920639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of the low-dose (20 mg) pravastatin GISSI Prevenzione trial in 4271 patients with recent myocardial infarction: do stopped trials contribute to overall knowledge? GISSI Prevenzione Investigators (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico).
    Ital Heart J; 2000 Dec; 1(12):810-20. PubMed ID: 11302109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-density lipoprotein cholesterol goal attainment among post myocardial infarction patients on lipid lowering therapy at Siriraj outpatient clinic.
    Praipaisarnkit K; Wongpraparut N; Pongakasira R
    J Med Assoc Thai; 2014 Mar; 97 Suppl 3():S147-54. PubMed ID: 24772592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals.
    Nakamura T; Obata JE; Hirano M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K
    Atherosclerosis; 2011 Sep; 218(1):163-7. PubMed ID: 21605862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-high-density lipoprotein cholesterol versus low-density lipoprotein cholesterol as a risk factor for a first nonfatal myocardial infarction.
    Farwell WR; Sesso HD; Buring JE; Gaziano JM
    Am J Cardiol; 2005 Oct; 96(8):1129-34. PubMed ID: 16214451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol Levels Decrease soon after Acute Myocardial Infarction.
    Rott D; Klempfner R; Goldenberg I; Leibowitz D
    Isr Med Assoc J; 2015 Jun; 17(6):370-3. PubMed ID: 26233997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of lipoprotein indices for residual risk of acute myocardial infarction and sudden death in men with low-density lipoprotein cholesterol levels <120 mg/dl.
    Tanaka F; Makita S; Onoda T; Tanno K; Ohsawa M; Itai K; Sakata K; Omama S; Yoshida Y; Ogasawara K; Ogawa A; Ishibashi Y; Kuribayashi T; Okayama A; Nakamura M;
    Am J Cardiol; 2013 Oct; 112(8):1063-8. PubMed ID: 23831165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
    Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
    Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of high-density lipoprotein cholesterol with periprocedural myocardial injury following elective percutaneous coronary intervention in patients with low-density lipoprotein cholesterol below 70 mg/dL.
    Li XL; Guo YL; Zhu CG; Xu RX; Qing P; Wu NQ; Jiang LX; Xu B; Gao RL; Li JJ
    J Am Heart Assoc; 2015 Jan; 4(1):e001412. PubMed ID: 25572484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-high-density lipoprotein cholesterol predicts nonfatal recurrent myocardial infarction in patients with ST segment elevation myocardial infarction.
    Gao M; Zheng Y; Zhang W; Cheng Y; Wang L; Qin L
    Lipids Health Dis; 2017 Jan; 16(1):20. PubMed ID: 28114933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
    Bonnet J; McPherson R; Tedgui A; Simoneau D; Nozza A; Martineau P; Davignon J;
    Clin Ther; 2008 Dec; 30(12):2298-313. PubMed ID: 19167589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PCSK9 R46L Loss-of-Function Mutation Reduces Lipoprotein(a), LDL Cholesterol, and Risk of Aortic Valve Stenosis.
    Langsted A; Nordestgaard BG; Benn M; Tybjærg-Hansen A; Kamstrup PR
    J Clin Endocrinol Metab; 2016 Sep; 101(9):3281-7. PubMed ID: 27218270
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.